JPH11506017A5 - - Google Patents
Info
- Publication number
- JPH11506017A5 JPH11506017A5 JP1997519267A JP51926797A JPH11506017A5 JP H11506017 A5 JPH11506017 A5 JP H11506017A5 JP 1997519267 A JP1997519267 A JP 1997519267A JP 51926797 A JP51926797 A JP 51926797A JP H11506017 A5 JPH11506017 A5 JP H11506017A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- mab
- ior
- generalized
- jelly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1995120A CU22584A1 (es) | 1995-11-17 | 1995-11-17 | Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis |
| CU120/95 | 1995-11-17 | ||
| PCT/CU1996/000004 WO1997019111A2 (es) | 1995-11-17 | 1996-11-18 | Anticuerpos monoclonales anti-cd6 y sus utilizaciones |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPH11506017A JPH11506017A (ja) | 1999-06-02 |
| JPH11506017A5 true JPH11506017A5 (https=) | 2008-03-13 |
| JP4113929B2 JP4113929B2 (ja) | 2008-07-09 |
Family
ID=5459401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51926797A Expired - Lifetime JP4113929B2 (ja) | 1995-11-17 | 1996-11-18 | アンチｃｄ６モノクロナール抗体とその利用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6572857B1 (https=) |
| EP (1) | EP0807125B1 (https=) |
| JP (1) | JP4113929B2 (https=) |
| KR (1) | KR100533854B1 (https=) |
| CN (1) | CN1222540C (https=) |
| AT (1) | ATE280783T1 (https=) |
| AU (1) | AU722882B2 (https=) |
| BR (1) | BRPI9607171B1 (https=) |
| CA (1) | CA2210751C (https=) |
| CU (1) | CU22584A1 (https=) |
| DE (1) | DE69633717T2 (https=) |
| DK (1) | DK0807125T3 (https=) |
| ES (1) | ES2231826T3 (https=) |
| PT (1) | PT807125E (https=) |
| WO (1) | WO1997019111A2 (https=) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1054316A1 (zh) * | 2000-05-26 | 2003-11-28 | Smithkline Beecham Corporation | 用於治疗rank配体介导疾病的抗-rank配体单克隆抗体 |
| CU23097A1 (es) | 2002-10-23 | 2005-11-18 | Centro Inmunologia Molecular | Método para la obtención de líneas celulares en medio libre de proteína y líneas celulares obtenidas por este método |
| US20070003568A1 (en) | 2003-02-24 | 2007-01-04 | Alice Dautry-Varsat | Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| KR101482956B1 (ko) * | 2006-12-26 | 2015-01-15 | 센트로 데 인뮤놀러지아 모레큘러 | 류마티스 관절염의 진단 및 치료에 사용되는 항-ｃｄ6 단일클론성 항체를 포함하는 약학 조성물 |
| KR101482959B1 (ko) | 2006-12-26 | 2015-01-15 | 센트로 데 인뮤놀러지아 모레큘러 | Ｂ-세포 만성 림프구성 백혈병의 진단 및 치료에 유용한 종양 세포에서 세포사멸을 유도할 수 있는 약학 조성물 |
| CA2711394A1 (en) | 2008-01-11 | 2009-07-16 | Synovex Corporation | Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders |
| WO2009113083A1 (en) * | 2008-03-14 | 2009-09-17 | Biocon Limited | A monoclonal antibody and a method thereof |
| RS57215B1 (sr) * | 2010-07-15 | 2018-07-31 | Adheron Therapeutics Inc | Humanizovana antitela koja ciljaju ec1 domen kadherina-11 i kompozicije i postupci koji su u vezi sa njima |
| WO2012019168A2 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP2625189B1 (en) | 2010-10-01 | 2018-06-27 | ModernaTX, Inc. | Engineered nucleic acids and methods of use thereof |
| AU2012236099A1 (en) | 2011-03-31 | 2013-10-03 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
| BR112013033988B1 (pt) | 2011-07-01 | 2021-10-19 | Beckman Coulter, Inc. | Métodos de identificação e isolamento de uma ou mais populações de células t regulatórias imunossupressoras |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| DE19216461T1 (de) | 2011-10-03 | 2021-10-07 | Modernatx, Inc. | Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon |
| CA3018046A1 (en) | 2011-12-16 | 2013-06-20 | Moderna Therapeutics, Inc. | Modified nucleoside, nucleotide, and nucleic acid compositions |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| US9254311B2 (en) | 2012-04-02 | 2016-02-09 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins |
| WO2013151665A2 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins associated with human disease |
| PL2922554T3 (pl) | 2012-11-26 | 2022-06-20 | Modernatx, Inc. | Na zmodyfikowany na końcach |
| FR3000216B1 (fr) * | 2012-12-21 | 2015-02-06 | Galderma Res & Dev | Utilisation de proteases particulieres pour la detection de trichophytons et de pathologies associees |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| EP3024485B1 (en) | 2013-07-23 | 2020-11-18 | Biocon Limited | Use of a cd6 binding partner and method based thereon |
| WO2015048744A2 (en) | 2013-09-30 | 2015-04-02 | Moderna Therapeutics, Inc. | Polynucleotides encoding immune modulating polypeptides |
| EP3052521A1 (en) | 2013-10-03 | 2016-08-10 | Moderna Therapeutics, Inc. | Polynucleotides encoding low density lipoprotein receptor |
| CN105504062B (zh) * | 2015-12-25 | 2019-06-04 | 百泰生物药业有限公司 | 一种抗CD6单抗T1h的检测性抗体及应用 |
| ES2991182T3 (es) | 2016-10-21 | 2024-12-02 | Biocon Ltd | Un anticuerpo monoclonal y un método de uso para el tratamiento del lupus |
| CN112424226B (zh) * | 2018-02-27 | 2025-03-14 | 平衡生物科技股份有限公司 | 用于治疗重度哮喘的抗cd6抗体 |
| US12281151B2 (en) | 2018-06-29 | 2025-04-22 | City Of Hope | CD6 targeted chimeric antigen receptors for treatment of certain autoimmune disorders |
| BR112021016967A2 (pt) | 2019-02-26 | 2021-11-23 | Equillium Inc | Composições de anticorpo anti-cd6 e métodos para tratar lúpus |
| WO2021138454A1 (en) | 2019-12-30 | 2021-07-08 | City Of Hope | Methods of making and using regulatory t cells and effector t cells having chimeric antigen receptors targeted to cd6, cd19, and/or an il-13r for treatment of autoimmune disorders and cancers |
| US20230151107A1 (en) * | 2020-04-04 | 2023-05-18 | Biocon Limited | Anti-cd6 antibody compositions and methods for treating and reducing negative effects of a coronavirus including covid-19 |
| CA3231281A1 (en) | 2021-09-08 | 2023-03-16 | Yanelda De Los Angeles Garcia Vega | Use of anti-cd6 monoclonal antibodies in the prevention of cellular and organ damage resulting from hyper-inflammatory response |
| WO2025096685A1 (en) | 2023-10-30 | 2025-05-08 | City Of Hope | Methods of making and using regulatory t cells for treatment of autoimmune disorders and cancers |
| CN120005027B (zh) * | 2025-04-10 | 2025-09-23 | 中国水产科学研究院长江水产研究所 | 大口黑鲈cd6抗原结合肽、及其单克隆抗体和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995012614A1 (en) * | 1993-11-02 | 1995-05-11 | Duke University | Cd6 ligand |
| CU22615A1 (es) * | 1994-06-30 | 2000-02-10 | Centro Inmunologia Molecular | Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos |
-
1995
- 1995-11-17 CU CU1995120A patent/CU22584A1/es unknown
-
1996
- 1996-11-18 JP JP51926797A patent/JP4113929B2/ja not_active Expired - Lifetime
- 1996-11-18 CN CNB96192098XA patent/CN1222540C/zh not_active Expired - Lifetime
- 1996-11-18 US US08/875,674 patent/US6572857B1/en not_active Expired - Lifetime
- 1996-11-18 EP EP96939805A patent/EP0807125B1/en not_active Expired - Lifetime
- 1996-11-18 ES ES96939805T patent/ES2231826T3/es not_active Expired - Lifetime
- 1996-11-18 AU AU76905/96A patent/AU722882B2/en not_active Ceased
- 1996-11-18 PT PT96939805T patent/PT807125E/pt unknown
- 1996-11-18 BR BRPI9607171A patent/BRPI9607171B1/pt not_active IP Right Cessation
- 1996-11-18 DE DE69633717T patent/DE69633717T2/de not_active Expired - Lifetime
- 1996-11-18 AT AT96939805T patent/ATE280783T1/de active
- 1996-11-18 DK DK96939805T patent/DK0807125T3/da active
- 1996-11-18 WO PCT/CU1996/000004 patent/WO1997019111A2/es not_active Ceased
- 1996-11-18 CA CA002210751A patent/CA2210751C/en not_active Expired - Lifetime
- 1996-11-18 KR KR1019970704893A patent/KR100533854B1/ko not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH11506017A5 (https=) | ||
| Hart et al. | Indomethacin: a new non-steroid anti-inflammatory agent | |
| AU664492B2 (en) | Method and composition for treating inflammatory bowel disorders | |
| CA2129541A1 (en) | Method of Promoting Nitrogen Retention in Humans | |
| KR920000324A (ko) | 필수 지방산 처리법 | |
| CA2406570A1 (en) | Dermal compositions containing coenzyme q as the active ingredient | |
| Perkins | Apnea with intramuscular colistin therapy | |
| RU95101385A (ru) | Продукты, содержащие g-csf и tnf связующие протеина | |
| Seedat et al. | Acute renal failure due to proliferative nephritis from snake bite poisoning | |
| US4369190A (en) | Analgesic composition and use thereof to ameliorate intractable pain | |
| US4678668A (en) | Method of reducing soft tissue swelling and pain | |
| JPH0585523B2 (https=) | ||
| US5331012A (en) | Topical pharmaceutical preparation for fever blisters and other viral infections and method of use | |
| US3636202A (en) | Treatment of rheumatoid arthritis and related diseases | |
| US4119713A (en) | Analgesic and anti-inflammatory composition | |
| US5716646A (en) | Methods and compositions for treating arthritis | |
| RU96115219A (ru) | Способ лечения больных сахарным диабетом | |
| Neary et al. | Development of extrapyramidal symptoms in hypertensive patients treated with diazoxide | |
| Furniss | Nonsteroidal anti-inflammatory agents in the treatment of primary dysmenorrhea | |
| RU2182006C2 (ru) | Способ лечения ревматоидного артрита | |
| RU95102611A (ru) | Способ лечения туберкулеза легких | |
| Yu et al. | Creatine derivatives: rapid complete relief of pain by topical or transcutaneous administration | |
| RU94000695A (ru) | Средство с противоаллергическим действием | |
| MICHELSON et al. | Treatment of cutaneous tuberculosis with large doses of vitamin D2 | |
| Lee | Age-related changes in gastric mucosal bicarbonate secretion in rats |